BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22357846)

  • 1. Neurochemical enhancement of conscious error awareness.
    Hester R; Nandam LS; O'Connell RG; Wagner J; Strudwick M; Nathan PJ; Mattingley JB; Bellgrove MA
    J Neurosci; 2012 Feb; 32(8):2619-27. PubMed ID: 22357846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks.
    Nandam LS; Hester R; Bellgrove MA
    Neuropsychologia; 2014 Apr; 56():263-70. PubMed ID: 24513025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability.
    Nandam LS; Hester R; Wagner J; Cummins TD; Garner K; Dean AJ; Kim BN; Nathan PJ; Mattingley JB; Bellgrove MA
    Biol Psychiatry; 2011 May; 69(9):902-4. PubMed ID: 21193172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoaminergic modulation of behavioural and electrophysiological indices of error processing.
    Barnes JJ; O'Connell RG; Nandam LS; Dean AJ; Bellgrove MA
    Psychopharmacology (Berl); 2014 Jan; 231(2):379-92. PubMed ID: 23995299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
    Kowalczyk OS; Cubillo AI; Smith A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.
    Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Liechti ME; Borgwardt S
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):712-720. PubMed ID: 28525569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study.
    Chou TL; Chia S; Shang CY; Gau SS
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2300-10. PubMed ID: 26409297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
    Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users.
    Hester R; Nestor L; Garavan H
    Neuropsychopharmacology; 2009 Oct; 34(11):2450-8. PubMed ID: 19553917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
    Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neural correlates of deficient error awareness in attention-deficit hyperactivity disorder (ADHD).
    O'Connell RG; Bellgrove MA; Dockree PM; Lau A; Hester R; Garavan H; Fitzgerald M; Foxe JJ; Robertson IH
    Neuropsychologia; 2009 Mar; 47(4):1149-59. PubMed ID: 19350709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
    Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
    Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
    Navarra R; Graf R; Huang Y; Logue S; Comery T; Hughes Z; Day M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):34-41. PubMed ID: 17714843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers.
    Simmons AN; Arce E; Lovero KL; Stein MB; Paulus MP
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1009-20. PubMed ID: 19545475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired error awareness in healthy older adults: an age group comparison study.
    Sim J; Brown FL; O'Connell RG; Hester R
    Neurobiol Aging; 2020 Dec; 96():58-67. PubMed ID: 32949902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction.
    Moeller SJ; Honorio J; Tomasi D; Parvaz MA; Woicik PA; Volkow ND; Goldstein RZ
    Cereb Cortex; 2014 Mar; 24(3):643-53. PubMed ID: 23162047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.
    Chamberlain SR; Hampshire A; Müller U; Rubia K; Del Campo N; Craig K; Regenthal R; Suckling J; Roiser JP; Grant JE; Bullmore ET; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2009 Apr; 65(7):550-5. PubMed ID: 19026407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.
    Bari A; Eagle DM; Mar AC; Robinson ES; Robbins TW
    Psychopharmacology (Berl); 2009 Aug; 205(2):273-83. PubMed ID: 19404616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.